France does not plan to use the international COVAX mechanism, designed to provide all states with future coronavirus vaccines on an equitable basis, in order to receive doses of drugs. Reported by Reuters.
вЂњFrance's position is quite transparent. We are not going to buy vaccine doses through COVAX,вЂќ a source in the country's health ministry told the agency. According to him, France expects to receive the vaccine through a mechanism agreed upon within the European Union. He added that Paris in general supports the initiative promoted by the World Health Organization (WHO) and will allocate funds for its development.
To date, it has not been possible to obtain an official comment from the French Ministry of Health on this issue.
Earlier, WHO Director-General Tedros Adanom Ghebreyesus announced that more than 170 countries have joined the COVAX mechanism. The deadline for confirmation of participation in the program is September 18. On its website, WHO notes that the first contributions are expected no later than 9 October 2020.
This mechanism aims to accelerate the search for an effective vaccine for all countries. The goal is to invest in about 12 different vaccines and ensure equitable early access to them when they are on the market. In addition, COVAX is supporting capacity building and procurement so that about 2 billion vaccine doses can be equitably distributed by the end of 2021. Under the terms of the program, high-income countries pay for the purchase of vaccines, thereby subsidizing 92 so-called funded states in this area. This вЂњpooled financingвЂќ model provides vaccine manufacturers with purchase guarantees even before their drugs are licensed and ensures access to the poorest countries.
The COVAX project is managed by the Global Alliance for Vaccines and Immunization (GAVI), the Coalition for Epidemic Preparedness Innovation (CEPI), the World Health Organization, as well as multinational vaccine manufacturers who see the tool as an additional source of government funding.